Related Experiment Video
Updated: Nov 18, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia
Parsa Mehraban Far1, Jacob Rullo1, James Farmer1
1Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada.
Purpose:
We describe a case vision-threatening sclerouveitis as a probable adverse drug reaction to ibrutinib.
Methods:
Case report.
Results:
Ibrutinib is an inhibitor of Bruton's kinase which has shown success in the treatment of hematological malignancies such as chronic lymphocytic leukemia. Despite being generally well tolerated, recent studies have implicated ibrutinib in several adverse events affecting organs such as the heart, intestines, and the eyes. We present the case of a patient who developed severe sclerouveitis after approximately one year of ibrutinib therapy, and suggest this is a probable adverse drug reaction associated with ibrutinib in accordance with the Naranjo algorithm, highlighting the importance of prompt management of ocular symptoms in these patients.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Angle Closure Glaucoma: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs for Treatment of Ulcerative Colitis in IBD

